Healthcare
PRF Technologies Ltd.(PRFX)
Live Price
Offline$1.65
-10.81% today
1Y Change
-77.40%
Window
Jun 23, 2025 โ Jun 18, 2026
- Market Cap
- โ
- Revenue Growth
- 0.0%
- EPS Growth
- +99.1%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 23, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
PRF Technologies Ltd. (PRFX) is a Healthcare stock with listed on NASDAQ. The stock last traded around $1.65 and down 77.4% across the available one-year price window (Jun 23, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +99.1%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +99.1%, free cash flow +68.7% with operating margin 0.0% and ROIC -33.9%. Stock Foundry combines PRFX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 6, 2026, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +99.1%, while operating margin sits near 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +6.9% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 6, 2026 | โ | -11.1% | +8.3% | -22.1% |
2025 Oct 2, 2025 | โ | +1.5% | +5.1% | -11.8% |
2025 Oct 1, 2025 | โ | -1.4% | +7.2% | -8.7% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PRFX
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PRFX Max Drawdown
-88.69%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PRFX and SPY.
Company Overview
PRF Technologies Ltd.
NASDAQ Capital Market
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
- Leadership
- Efraim Cohen-Arazi
- IPO Date
- Sep 1, 2020
- Employees
- 2
- Street Address
- 65 Yigal Alon Street
- Mailing
- Tel Aviv, 6745442
- Region
- Tel Aviv, IL
- Reporting Currency
- USD
- Investor Line
- 972 3 717 7050
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 1.0
- Price/Sales
- โ
- Price/Book
- 0.0
Growth
- Revenue
- 0.0%
- EPS
- +99.1%
- Free Cash Flow
- +68.7%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- -47.0%
- ROIC
- -33.9%
Balance Sheet
- Debt/Equity
- 0.00
- Current Ratio
- 1.78
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.